MedTrace Logo

Testing Informed Decision Making in Lung Cancer Screening

NCT04940221 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2023-09-18

Study results available
· View outcomes & findings →

Summary

Lung cancer screening rates are very low despite the fact that lung cancer screening could save many lives. People need to understand the risks and benefits to screening as well as their own beliefs about screening. This study builds an intervention in real world primary care that will help people make the right decision for them as well as help people to quit smoking. Interventions like this are needed to improve the screening rate and reduce death from lung cancer, which is the leading cancer killer.

Conditions

Interventions

BEHAVIORAL

Shared Decision Making

Telephone delivered non-persuasive shared decision-making for lung cancer screening.

Sponsors & Collaborators

  • Thomas Jefferson University

    collaborator OTHER

  • University of Delaware

    collaborator OTHER

  • National Institute of General Medical Sciences (NIGMS)

    collaborator NIH

  • Christiana Care Health Services

    lead OTHER

Principal Investigators

  • Heather B Fagan, MD · Christiana Care Health Services

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
55 Years
Max Age
78 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-07-18
Primary Completion
2020-09-30
Completion
2020-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04940221 on ClinicalTrials.gov